|
Post by otherottawaguy on May 2, 2017 16:52:38 GMT -5
from cedarfuntenis:
What is the probability that the company will still be afloat and listed on the NASDAQ at this time next year?
|
|
|
Post by ssiegel on May 2, 2017 17:53:55 GMT -5
Question #1. 3 parts A.Has MNKD been in talks with the FDA ? B. Have they asked for any further information in regards to the label change and or the TV Commercial? C. Have they gave you any indication that either one will be approved shortly? Has MNKD ever stated exactly what label change they are interested in obtaining? I've seen various comments here to the effect that it has to do with "ultrafast," but has MNKD itself ever stated that anywhere?
|
|
|
Post by peppy on May 2, 2017 19:03:32 GMT -5
What is the plan to stay alive as an entity?
|
|
|
Post by anderson on May 2, 2017 19:07:55 GMT -5
Why hasn't a full time sales team been able to break 300 scripts per week - given the length of time they've been in the field. How are you addressing the barriers to sales/scripts? Same as above just asked differently. Revenue and scripts have been the same for over a year. The sales team wither contract or full time have not be able to increase these numbers. The steady state has to be due to drop outs, so why are there so many people who drop out of using Afrezza and what can be done to address this?
|
|
|
Post by blueice on May 2, 2017 23:26:03 GMT -5
2. What advice or encouragement would you offer to long term investors who have believed in Al & this life changing technology that they did not do so in vain (and you cannot say 'stay tuned')?
|
|
|
Post by nylefty on May 2, 2017 23:47:32 GMT -5
Isn't it time to drastically lower the price of Afrezza in order to not only boost sales but also to get some badly-needed positive publicity?
|
|
|
Post by sportsrancho on May 3, 2017 8:06:43 GMT -5
How much conflict is there between the BOD, the AEMF, and management, on how to move the company forward?
|
|
|
Post by slugworth008 on May 3, 2017 9:10:36 GMT -5
Where is the uptick in scripts as referenced in the last CC?
|
|
|
Post by techorfund on May 3, 2017 11:45:27 GMT -5
Matt, have you considered other alternative funding sources, like setting up a "Go Fund Me" account for MNKD?
|
|
|
Post by u1682002 on May 3, 2017 14:40:11 GMT -5
Can MNKD operate to FDA label change decision point without further dilution?
|
|
bac
Lab Rat
Posts: 37
|
Post by bac on May 3, 2017 15:20:02 GMT -5
Which BOD members have insulin marketing and/or insulin sales expertise?
|
|
|
Post by tiberious on May 3, 2017 15:28:31 GMT -5
Simple question... what is your path forward to stave off bankruptcy Matt?
|
|
|
Post by petech on May 3, 2017 16:50:47 GMT -5
Here's my question, sorry if it is too long:
From the embarrassment of publicly disclosing DeSisto as the new CEO only to realize he had a non-compete, to the year-long plus partnership with Sanofi where we seemingly sat on our hands and never thought to raise capital despite knowing Sanofi and you were not on the same page, to the year-long plus since we've gotten back Afrezza and have waivered from contract sales force to in house sales force etc., it seems unfortunately clear that foresight is at a premium with MNKD. Can you provide us with guidance as to what sales numbers you intend to hit this year (and next), when you are going to hit them, and what you are going to do to fund operations until this point? In the past, I've accepted the "competitive reasons to not disclose" excuse but I am all but convinced there is no plan and it is leading by reaction rather than strategically.
|
|
|
Post by mockingjay on May 3, 2017 17:33:10 GMT -5
My question is: Matt , how can I kick you out ?
|
|
|
Post by roseylv on May 3, 2017 17:53:20 GMT -5
Directed at Mike C.
Mike, can you speak to the statistics of our in-house sales team, perhaps shed some light on how many Doctor drop in's they are each averaging per day / week and of those, what percentage of the new visits results in a converted doctor?
|
|